← Back to Clinical Trials
Recruiting NCT06579560

NCT06579560 Audio Vestibular Assessment in Patients with Fibromyalgia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06579560
Status Recruiting
Phase
Sponsor Noha Osman
Condition Fibromyalgia
Study Type OBSERVATIONAL
Enrollment 4 participants
Start Date 2023-04-16
Primary Completion 2025-04-16

Trial Parameters

Condition Fibromyalgia
Sponsor Noha Osman
Study Type OBSERVATIONAL
Phase N/A
Enrollment 4
Sex ALL
Min Age 15 Years
Max Age 50 Years
Start Date 2023-04-16
Completion 2025-04-16
Interventions
Audiovestibular assessment in Patients with Fibromyalgia

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Fibromyalgia (FM) is a common rheumatic illness distinguished by chronic pain, fatigue, cognitive problems, and functional disability. However, the differences between men and women have not yet been comprehensively studied, especially after the development of the last 2016 American College of Rheumatology (ACR) criteria. The disease is more common and more severe in female patients according to a study on gender differences among Egyptian patients (A. Moshrif et al., 2023)

Eligibility Criteria

1. Inclusion criteria: - Age: 15-50 years. * Sex: Male \& Female. * Patients with fulfilling the criteria for the diagnosis of FM 2. Exclusion criteria: Patients not fulfilling the criteria for the diagnosis of FM. * Other causes of SNHL as Meniere's disease. * Other causes of Conductive hearing loss (CHL) as chronic suppurative otitis media CSOM. * Other causes of collagen and connective tissue diseases. * Abnormal EMG. * Abnormal radiological studies of the brain. * Patients are receiving of ototoxic drugs.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology